Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls

J Comput Assist Tomogr. 2005 Mar-Apr;29(2):205-9. doi: 10.1097/01.rct.0000159510.13694.8c.

Abstract

The purpose of this pictorial essay is to illustrate a spectrum of normal variants and potential pitfalls in integrated positron emission tomography (PET)/computed tomography (CT) imaging in the evaluation of patients with non-small cell lung cancer. Knowledge of the normal variants and potential pitfalls in PET/CT imaging as well as patients' clinical histories, together with the use of CT to localize foci of increased tracer uptake accurately, is useful in preventing misinterpretation.

MeSH terms

  • Adipose Tissue, Brown / pathology
  • Aged
  • Arteriosclerosis / diagnosis
  • Arteriosclerosis / pathology
  • Artifacts
  • Blood Glucose / metabolism
  • Carcinoma, Non-Small-Cell Lung / diagnosis*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Contrast Media / administration & dosage
  • Contrast Media / pharmacokinetics
  • Diagnosis, Differential
  • Diagnostic Errors
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Humans
  • Iatrogenic Disease
  • Image Processing, Computer-Assisted* / instrumentation*
  • Lung / pathology
  • Lung Neoplasms / diagnosis*
  • Male
  • Middle Aged
  • Muscle, Skeletal / pathology
  • Neoplasm Staging
  • Positron-Emission Tomography / instrumentation*
  • Reference Values
  • Sensitivity and Specificity
  • Tomography, Spiral Computed / instrumentation*

Substances

  • Blood Glucose
  • Contrast Media
  • Fluorodeoxyglucose F18